We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+10.89%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$14.8B
AUM Growth
+$1.41B
Cap. Flow
-$396M
Cap. Flow %
-2.67%
Top 10 Hldgs %
34.28%
Holding
1,311
New
31
Increased
615
Reduced
268
Closed
37

Top Buys

Rank Stock Value
1
AVB icon
AvalonBay Communities
AVB
+$175M
2
EQIX icon
Equinix
EQIX
+$158M
3
AMT icon
American Tower
AMT
+$91.5M
4
KIM icon
Kimco Realty
KIM
+$76.2M
5
SOCL icon
Global X Social Media ETF
SOCL
+$43.2M

Top Sells

Rank Stock Value
1
INVH icon
Invitation Homes
INVH
+$172M
2
MAA icon
Mid-America Apartment Communities
MAA
+$148M
3
MPT
Medical Properties Trust
MPT
+$126M
4
VICI icon
VICI Properties
VICI
+$115M
5
DLR icon
Digital Realty Trust
DLR
+$97.3M

Sector Composition

Rank Sector Weight
1 Real Estate 59.19%
2 Technology 7.88%
3 Communication Services 4.43%
4 Consumer Discretionary 3.51%
5 Financials 3.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBIO icon
1001
BridgeBio Pharma
BBIO
$16.5B
$18K ﹤0.01%
295
– –
OUT icon
1002
Outfront Media
OUT
$5.68B
$18K ﹤0.01%
747
+75
+11% +$1.74K
ARGX icon
1003
argenx
ARGX
$55.6B
$17K ﹤0.01%
55
+6
+12% +$1.71K
ARWR icon
1004
Arrowhead Research
ARWR
$12B
$17K ﹤0.01%
206
– –
FATE icon
1005
Fate Therapeutics
FATE
$283M
$16K ﹤0.01%
186
– –
UTHR icon
1006
United Therapeutics
UTHR
$26.3B
$16K ﹤0.01%
88
– –
MRTX
1007
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$16K ﹤0.01%
100
– –
BEAM icon
1008
Beam Therapeutics
BEAM
$2.58B
$15K ﹤0.01%
115
– –
CM icon
1009
Canadian Imperial Bank of Commerce
CM
$108B
$15K ﹤0.01%
270
– –
GEN icon
1010
PUT
Gen Digital
GEN
$16.1B
$15K ﹤0.01%
2,000
-444
-18% -$11.1K
XLRN
1011
DELISTED
Acceleron Pharma
XLRN
$15K ﹤0.01%
120
– –
MEDP icon
1012
Medpace
MEDP
$16.5B
$13K ﹤0.01%
71
– –
PACB icon
1013
Pacific Biosciences
PACB
$422M
$13K ﹤0.01%
382
– –
RARE icon
1014
Ultragenyx Pharmaceutical
RARE
$2.65B
$13K ﹤0.01%
133
– –
TWST icon
1015
Twist Bioscience
TWST
$5.39B
$13K ﹤0.01%
96
– –
HALO icon
1016
Halozyme
HALO
$9.66B
$12K ﹤0.01%
268
– –
NWS icon
1017
News Corp Class B
NWS
$16.8B
$12K ﹤0.01%
511
– –
VIR icon
1018
Vir Biotechnology
VIR
$1.48B
$12K ﹤0.01%
253
– –
ADPT icon
1019
Adaptive Biotechnologies
ADPT
$3.61B
$11K ﹤0.01%
276
– –
CLPR
1020
Clipper Realty
CLPR
$46.4M
$11K ﹤0.01%
1,500
– –
EXEL icon
1021
Exelixis
EXEL
$14B
$11K ﹤0.01%
618
– –
IBRX icon
1022
ImmunityBio
IBRX
$7.32B
$11K ﹤0.01%
746
+530
+245% +$8.76K
IONS icon
1023
Ionis Pharmaceuticals
IONS
$9.25B
$11K ﹤0.01%
279
-5,497
-95% -$215K
APLS
1024
DELISTED
Apellis Pharmaceuticals
APLS
$10K ﹤0.01%
159
– –
BPMC
1025
DELISTED
Blueprint Medicines
BPMC
$10K ﹤0.01%
115
– –
39 40
41
42 43

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2021 Portfolio in Review

As of Q2 2021, Daiwa Securities Group held 1,311 positions worth $14.8B, up 10% from $13.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group's Q2 2021 filing shows 31 new, 615 increased, 268 reduced and 37 closed positions. Its largest new stake was Algonquin Power & Utilities Corp Units: 325,000 shares worth $16.1M. The largest sale was Invitation Homes, an estimated $172M.

By sector, the portfolio is most concentrated in Real Estate at 59% of assets, down from 61% a quarter earlier, followed by Technology and Communication Services.

  • Daiwa Securities Group's largest Q2 2021 buy was Algonquin Power & Utilities Corp Units: 325,000 shares worth $16.1M.
  • Daiwa Securities Group added most to AvalonBay Communities in Q2 2021, an estimated $175M increase.
  • Daiwa Securities Group's biggest Q2 2021 reduction was Invitation Homes, cutting an estimated $172M.
  • Daiwa Securities Group fully exited Global X Cloud Computing ETF in Q2 2021, selling an estimated $29.5M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $14.8B portfolio in Q2 2021.
  • Daiwa Securities Group opened 31 new positions and closed 37 in Q2 2021.
  • Daiwa Securities Group's portfolio value rose 10% quarter-over-quarter to $14.8B.

Based on Daiwa Securities Group's 13F filing for Q2 2021, filed 6 Aug 2021.